Medication Management for Bariatric Surgery

1. Summarize the types of bariatric surgery and candidates for bariatric surgery.
2. Explain the clinical pharmacists’ role in bariatric medication management.
3. Identify general procedural and medical clearance elements to consider prior to bariatric surgery.
4. Identify general counseling and medication management elements pre/post bariatric surgery.
5. Evaluate medication management for certain chronic disease states such as hypertension, diabetes, and hyperlipidemia in patient pre/post bariatric surgery.
6. Describe a vitamin and supplement therapy plan to prevent or treat nutrient deficiencies in patients pre/post-bariatric surgery.
7. Discuss the bariatric surgery program at Evans Army Community Hospital.
8. Provide the documentation and billing process utilized by clinical pharmacists for bariatric services

Treatment of Depression and Anxiety in Pregnancy and Lactation

1. Recognize the prevalence of depression in pregnancy.
2. Discuss the pathophysiology of depression in pregnancy.
3. Evaluate the treatment options for depression in pregnancy.

Pharmacogenomics: The Foundation

1. Identify cellular microbiology content and processes.
2. Explain the pharmacogenomics (PGx) field.
3. Describe pharmacokinetic/pharmacodynamics principles and application to drug absorption, distribution, metabolism and elimination (ADME) involved in PGx.
4. Organize PGx-specific tools/resources.
5. Develop a plan for further pharmacist training and use of core competencies.
6. Describe varying practice models.
7. Evaluate clinical protocols for application.
8. Analyze CYP 2C19 and clopidogrel specific guideline.
9. Analyze the newly updated G6PD-specific guidelines, and current system alert.
10. Apply resources to patient case examples (CPIC, PharmGKB).
11. Summarize the Implementation Toolkit resources.

Pharmacogenomics in Mental Health

1. List resources for pharmacogenomics (PGx) prescribing information.
2. Describe the evidence of pharmacogenomics in mental health prescribing.
3. Modify mental health medications based on an individuals’ PGx results
4. Utilize PGx in patient case

The Smart Guide to Lipid Management: What  you need to Know, What you Need to Do

1. Interpret and apply the 2018 American Heart Association/American College of Cardiology (ACC)/Multi-society guidelines for cholesterol management in adults.
2. Implement updated LDL-C and non-HDL-C goals from the 2022 ACC Expert Consensus Statement and confidently select appropriate add-on therapies for patients not at target.
3. Recognize and appropriately utilize alternative lipid monitoring parameters in select patient groups, considering their cost-effectiveness and impact on healthcare expenditures.
4. Effectively evaluate and manage statin intolerance in patients.
5. Identify and describe emerging lipid-lowering therapeutics, with a focus on agents targeting Lipoprotein(a).

Infectious Disease Review for the Ambulatory Care Pharmacist

1. Recall infectious disease states for which antimicrobial therapy is not commonly recommended.
2. Summarize various antibiotic therapy for infectious diseases in the ambulatory care setting for adult patients.
3. Develop appropriate and guideline-based antimicrobial regimens.

2025 Diabetes Updates

1. Explain prevention strategies to avoid or delay development of type 2 diabetes mellitus (T2DM).
2. Describe diagnosis and classification of Diabetes.
3. Review comprehensive evaluation and assessment of comorbidities of T2DM.
4. Discuss nonpharmacological therapy for diabetes, such as diabetes self-management education and support, medical nutrition therapy, and exercise. 
5. Recall appropriate glycemic goals.
6. Describe obesity and weight management strategies in patients with T2DM.
7. Discuss pharmacologic therapy for T2DM.
8. Describe risk management strategies for chronic kidney disease, retinopathy, neuropathy, and foot care.

Contraceptive Management

1. Review brief history of contraception.
2. Describe the role of the provider in both preconception and contraception care.
3. Review contraceptives available.
4. Outline current guidelines for contraceptive management.
5. Apply knowledge to patient cases.

Cystic Fibrosis: A Pharmacist’s Role in Optimizing Patient Care

1. Discuss clinical cystic fibrosis (CF) features and symptoms.
2. List common CF therapeutic agents.
3. Identify risks and benefits of the different treatment options.

Anticoagulation – Warfarin: Initiation, Monitoring & Bridging DOACs: Balancing Bleeds & Weight Extremes

1. Decide which patients require warfarin over direct-acting oral anticoagulant (DOACs).
2. Determine outpatient management of venous thromboembolism (initiation, follow up, duration).
3. Describe appropriate transition to and from warfarin.
4. Discuss low/high weight DOAC use.
5. Discuss when/how long to hold anticoagulation prior to procedures.
6. Discuss factors dictating the restart of anticoagulation after procedure and/or bleeding
7. Describe the SPARCtool, MAQI2, MHSG AC Workflow, and RapidRecap tools.
8. Explain the typical length of therapy based on diagnosis.
9. Discuss follow up intervals for DOAC therapy.

Continuous Glucose Monitors

1. Compare and contrast continuous glucose monitoring technologies.
2. Identify appropriate candidates and optimize use of continuous glucose monitors (CGMs).
3. Interpret CGM data and formulate appropriate therapeutic recommendations.

Drug Therapy for Weight Management

1. Summarize the current guideline recommendations for weight loss management.
2. Evaluate the current evidence supporting use of each class of anti-obesity medication.
3. Describe the prior authorization process for anti-obesity medications under Tricare formulary.
4. Apply a weight loss management plan incorporating lifestyle intervention and pharmacotherapy for a patient who is a candidate for anti-obesity medication.

Menopause and Female Sexual Dysfunction

1. Review female reproductive life cycle.
2. Describe the role of the provider in treatment of genitourinary syndrome of menopause (GSM) and vulvovaginal atrophy (VVA).
3. Review therapies available for treatment of GSM and VVA.
4. Outline current guidelines for treatment of menopause symptoms.
5. Review the type of female sexual dysfunction.
6. Review pharmacotherapy treatments for female sexual dysfunction.

GLP-1RA Beyond Diabetes and Weight Management

1. Explain GLP-1 and GIP receptor sites and actions.
2. List GLP-1RA and GIP/GLP-1RA agents and their FDA approved indications.
3. Discuss outcomes data on GLP-1RA and GIP/GLP1-RA agents.
4. Discuss potential indications for GLP-1RA and GIP/GLP1-RA agents beyond currently FDA approved indications.